APA (7th ed.) Citation

N, E., M, A., H, v. B., C, G., M, P., A, A., . . . S, Y. (2026). Real-World Assessment of Prophylactic Anakinra on Neurotoxicity and Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed and Refractory B-Cell Lymphoma: An Inverse Probability of Treatment Weighting Analysis. Transplantation and cellular therapy. https://doi.org/10.1016/j.jtct.2026.06.008

Chicago Style (17th ed.) Citation

N, Easton, et al. "Real-World Assessment of Prophylactic Anakinra on Neurotoxicity and Cytokine Release Syndrome After CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed and Refractory B-Cell Lymphoma: An Inverse Probability of Treatment Weighting Analysis." Transplantation and Cellular Therapy 2026. https://doi.org/10.1016/j.jtct.2026.06.008.

MLA (9th ed.) Citation

N, Easton, et al. "Real-World Assessment of Prophylactic Anakinra on Neurotoxicity and Cytokine Release Syndrome After CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed and Refractory B-Cell Lymphoma: An Inverse Probability of Treatment Weighting Analysis." Transplantation and Cellular Therapy, 2026, https://doi.org/10.1016/j.jtct.2026.06.008.